Identity
HGNC
LOCATION
Xq26.2
LOCUSID
ALIAS
K-glypican,KPTS
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 2239
MIM: 300168
HGNC: 4452
Ensembl: ENSG00000076716
Variants:
dbSNP: 2239
ClinVar: 2239
TCGA: ENSG00000076716
COSMIC: GPC4
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000076716 | ENST00000370828 | O75487 |
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38424123 | 2024 | Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson's disease. | 0 |
| 38424123 | 2024 | Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson's disease. | 0 |
| 37511353 | 2023 | The Shear Stress-Regulated Expression of Glypican-4 in Endothelial Dysfunction In Vitro and Its Clinical Significance in Atherosclerosis. | 0 |
| 37844682 | 2023 | Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure. | 0 |
| 37511353 | 2023 | The Shear Stress-Regulated Expression of Glypican-4 in Endothelial Dysfunction In Vitro and Its Clinical Significance in Atherosclerosis. | 0 |
| 37844682 | 2023 | Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure. | 0 |
| 35202959 | 2022 | Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients. | 4 |
| 35944770 | 2022 | Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease. | 2 |
| 35202959 | 2022 | Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients. | 4 |
| 35944770 | 2022 | Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease. | 2 |
| 32199612 | 2020 | Downregulation of glypican-4 facilitates breast cancer progression by inducing cell migration and proliferation. | 13 |
| 32199612 | 2020 | Downregulation of glypican-4 facilitates breast cancer progression by inducing cell migration and proliferation. | 13 |
| 30982611 | 2019 | Pathogenic Variants in GPC4 Cause Keipert Syndrome. | 13 |
| 31217057 | 2019 | Serum Glypican 4 Levels Are Associated with Metabolic Syndrome in a Han Population from Guizhou Province, China. | 4 |
| 31484922 | 2019 | CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis. | 85 |
Citation
Dessen P
GPC4 (glypican 4)
Atlas Genet Cytogenet Oncol Haematol. 2003-05-01
Online version: http://atlasgeneticsoncology.org/gene/40736/gpc4-(glypican-4)
